Hippocampus Glutamate and N-Acetyl Aspartate Markers of Excitotoxic Neuronal Compromise in Posttraumatic Stress Disorder

Neuropsychopharmacology

Volumn 42, Issue 8, 2017, Pages 1698-1705

  Rosso, Isabelle M ^a,b   Crowley, David J ^a   Silveri, Marisa M ^a,b   Rauch, Scott L ^a,b   Jensen, J Eric ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; N ACETYLASPARTIC ACID; ASPARTIC ACID; BIOLOGICAL MARKER; N-ACETYLASPARTATE;

ADULT; AMINO ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; EXCITOTOXICITY; FEMALE; HUMAN; LEFT HIPPOCAMPUS; MALE; NERVE CELL; NEUROIMAGING; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RIGHT HIPPOCAMPUS; TREATMENT RESPONSE; ANALOGS AND DERIVATIVES; CASE CONTROL STUDY; HIPPOCAMPUS; INJURY; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADULT; ASPARTIC ACID; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; GLUTAMIC ACID; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; PROTON MAGNETIC RESONANCE SPECTROSCOPY; STRESS DISORDERS, POST-TRAUMATIC; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 85014521438     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2017.32     Document Type: Article

References (49)

1. Adamec R, Hebert M, Blundell J, Mervis RF (2012). Dendritic morphology of amygdala and hippocampal neurons in more and less predator stress responsive rats and more and less spontaneously anxious handled controls. Behav Brain Res 226: 133-146.
2. Banasr M, Chowdhury GMI, Terwilliger R, Newton SS, Duman RS, Behar KL et al (2010). Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry 15: 501-511.
3. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS et al (1995). The development of a clinicianadministered PTSD scale. J Trauma Stress 8: 75-90.
4. Bremner D, Mletzko T, Welter S, Siddiq S, Reed L, Williams C et al (2004). Treatment of posttraumatic stress disorder with phenytoin: an open-label pilot study. J Clin Psychiatry 65: 1559-1564.
5. Bremner JD, Randall P, Scott TM, Bronen RA, Seibyl JP, Southwick SM et al (1995). MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry 152: 973-981.
6. Brown S, Freeman T, Kimbrell T, Cardwell D, Komoroski R (2003). In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of former prisoners of war with and without posttraumatic stress disorder. J Neuropsychiatry Clin Neurosci 15: 367-370.
7. Burtscher IM, Holtas S (2001). Proton MR spectroscopy in clinical routine. J Magn Reson Imaging 13: 560-567.
8. Chambers RA, Bremner JD, Moghaddam B, Southwick SM, Charney DS, Krystal JH (1999). Glutamate and post-traumatic stress disorder: toward a psychobiology of dissociation. Semin Clin Neuropsychiatry 4: 274-281.
9. Doelken MT, Mennecke A, Stadlbauer A, Kecskeméti L, Kasper BS, Struffert T et al (2010). Multi-voxel magnetic resonance spectroscopy at 3T in patients with idiopathic generalised epilepsy. Seizure 19: 485-492.
10. First MB, Spitzer RL, Gibbon M, Williams JBW (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Patient Edition (SCID-I/P). Biometrics Research, New York State Psychiatric Institute: New York, USA.
11. Freeman TW, Cardwell D, Karson CN, Komoroski RA (1998). In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of subjects with combat-related posttraumatic stress disorder. Magn Reson Med 40: 66-71.
12. Gilbertson MW, Shenton ME, Ciszewski A, Kasai K, Lasko NB, Orr SP et al (2002). Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat Neurosci 5: 1242-1247.
13. Ham B-J, Chey J, Yoon SJ, Sung Y, Jeong D-U, Ju Kim S et al (2007). Decreased N-acetyl-aspartate levels in anterior cingulate and hippocampus in subjects with post-traumatic stress disorder: a proton magnetic resonance spectroscopy study. Eur J Neurosci 25: 324-329.
14. Helms G, Ciumas C, Kyaga S, Savic I (2006). Increased thalamus levels of glutamate and glutamine (Glx) in patients with idiopathic generalised epilepsy. J Neurol Neurosurg Psychiatry 77: 489-494.
15. Jensen JE, Licata SC, Ongur D, Friedman SD, Prescot AP, Henry ME et al (2009). Quantification of J-resolved proton spectra in two-dimensions with LCModel using GAMMAsimulated basis sets at 4 Tesla. NMR Biomed 22: 762-769.
16. Jing H, Lin M (2010). Study of the features of proton MR spectroscopy (1H-MRS) on amyotrophic lateral sclerosis. J Magn Reson Imaging 31: 305-308.
17. Karl A, Schaefer M, Malta LS, Dorfel D, Rohleder N, Werner A (2006). A meta-analysis of structural brain abnormalities in PTSD. Neurosci Biobehav Rev 30: 1004-1031.
18. Karl A, Werner A (2010). The use of proton magnetic resonance spectroscopy in PTSD research - Meta-analyses of findings and methodological review. Neurosci Biobehav Rev 34: 7-22.
19. Kitayama N, Vaccarino V, Kutner M, Weiss P, Bremner JD (2005). Magnetic resonance imaging (MRI) measurement of hippocampal volume in posttraumatic stress disorder: A meta-analysis. J Affect Disord 88: 79-86.
20. Krystal JH, Karper LP, Seibyl J, Freeman G, Delaney R, Bremner J et al (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199-214.
21. Kubany ES, Haynes SN, Leisen MB, Owens JA, Kaplan A, Watson SB et al (2000). Development and preliminary validation of a brief broad-spectrum measure of trauma exposure: the Traumatic Life Events Questionnaire. Psychol Assess 12: 210-224.
22. Lewerenz J, Maher P (2015). Chronic glutamate toxicity in neurodegenerative diseases - What is the evidence? Front Neurosci 9: 469.
23. Lindauer RJL, Olff M, Van Meijel EPM, Carlier IVE, Gersons BPR (2006). Cortisol, learning, memory, and attention in relation to smaller hippocampal volume in police officers with posttraumatic stress disorder. Biol Psychiatry 59: 171-177.
24. Mahmutyazicioglu K, Konuk N, Ozdemir H, Atasoy N, Atik L, Gundogdu S (2005). Evaluation of the hippocampus and the anterior cingulate gyrus by proton MR spectroscopy in patients with post-traumatic stress disorder. Diagn Interv Radiol 11: 125-129.
25. Manganas LN, Zhang X, Li Y, Hazel RD, Smith SD, Wagshui ME et al (2007). Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain. Science 318: 980-985.
26. Mark LP, Prost RW, Ulmer JL, Smith MM, Daniels DL, Strottmann JM et al (2001). Pictorial review of glutamate excitotoxicity: Fundamental concepts for neuroimaging. Am J Neuroradiol 22: 1813-1824.
27. Mason GF, Krystal JH (2006). MR spectroscopy: Its potential role for drug development for the treatment of psychiatric diseases. NMR Biomed 19: 690-701.
28. McEwen BS (2006). Protective and damaging effects of stress mediators: Central role of the brain. Dialogues Clin Neurosci 8: 367-381.
29. McEwen BS (2007). Physiology and neurobiology of stress and adaptation: Central role of the brain. Physiol Rev 87: 873-904.
30. McEwen BS, Magarinos AM (1997). Stress effects on morphology and function of the hippocampus. Ann NY Acad Sci 821: 271-284.
31. Nakano T, Wenner M, Inagaki M, Kugaya A, Akechi T, Matsuoka Y et al (2002). Relationship between distressing cancer-related recollections and hippocampal volume in cancer survivors. Am J Psychiatry 159: 2087-2093.
32. Neylan TC, Schuff N, Lenoci M, Yehuda R,Weiner MW,Marmar CR (2003). Cortisol levels are positively correlated with hippocampal N-acetylaspartate. Biol Psychiatry 54: 1118-1121.
33. Popoli M, Yan Z, McEwen BS, Sanacora G (2012). The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci 13: 22-37.
34. Provencher SW (1993). Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30: 672-679.
35. Pruessner JC, Li LM, Serles W, Pruessner M, Collins DL, Kabany N et al (2000). Volumetry of hippocampus and amygdala with highresolution MRI and three-dimensional analysis software: minimizing the discrepancies between laboratories. Cereb Cortex 10: 433-442.
36. Rauch SL, Shin LM, Phelps EA (2006). Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research-past, present, and future. Biol Psychiatry 60: 376-382.
37. Ressler KJ, Mercer KB, Bradley B, Jovanovic T, Mahan A, Kerley K et al (2011). Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 470: 492-497.
38. Rothman DL, Sibson NR, Hyder F, Shen J, Behar KL, Shulman RG (1999). In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics. Philos Trans R Soc Lond B Biol Sci 354: 1165-1177.
39. Sapolsky RM (1996). Why stress is bad for your brain. Science 273: 749-750.
40. Savic I, Thomas AM, Ke Y, Curran J, Fried I, Engel J (2000). In vivo measurements of glutamine+glutamate (Glx) and N-acetyl aspartate (NAA) levels in human partial epilepsy. Acta Neurol Scand 102: 179-188.
41. Schuff N, Neylan TC, Fox-Bosetti S, Lenoci M, Samuelson KW, Studholme C et al (2008). Abnormal N-acetylaspartate in hippocampus and anterior cingulate in posttraumatic stress disorder. Psychiatry Res Neuroimag 162: 147-157.
42. Schuff N, Neylan TC, Lenoci MA, Du AT, Weiss DS, Marmar CR et al (2001). Decreased hippocampal N-acetylaspartate in the absence of atrophy in posttraumatic stress disorder. Biol Psychiatry 50: 952-959.
43. Shu XJ, Xue L, Liu W, Chen FY, Zhu C, Sun XH et al (2013). More vulnerability of left than right hippocampal damage in righthanded patients with post-traumatic stress disorder. Psychiatry Res 212: 237-244.
44. Silveri MM, Sneider JT, Crowley DJ, Covell MJ, Acharya D, Rosso IM et al (2013). Frontal lobe gamma-aminobutyric acid levels during adolescence: associations with impulsivity and response inhibition. Biol Psychiatry 74: 296-304.
45. Smith ME (2005). Bilateral hippocampal volume reduction in adults with post-traumatic stress disorder: a meta-analysis of structural MRI studies. Hippocampus 15: 798-807.
46. Srinivasan R, Sailasuta N, Hurd R, Nelson S, Pelletier D (2005). Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3T. Brain 128: 1016-1025.
47. Tisell A, Leinhard OD, Warntjes JBM, Aalto A, Smedby Ö, Landtblom AM et al (2013). Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans. PLoS ONE 8: e61817
48. Villarreal G, Hamilton DA, Petropoulos H, Driscoll I, Rowland LM, Griego JA et al (2002). Reduced hippocampal volume and total white matter volume in posttraumatic stress disorder. Biol Psychiatry 52: 119-125.
49. Woon FL, Sood S, Hedges DW (2010). Hippocampal volume deficits associated with exposure to psychological trauma and posttraumatic stress disorder in adults: A meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 34: 1181-1188.